PPHE Hotel Group Limited (LON:PPH)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX | Market Cap | 633.74M +9.9% |
| Revenue (ttm) | 475.78M +5.3% |
| Net Income | 155.57M +609.7% |
| EPS | 3.66 +612.1% |
| Shares Out | 41.86M |
| PE Ratio | 4.14 |
| Forward PE | 12.94 |
| Dividend | 0.39 (2.58%) |
| Ex-Dividend Date | Sep 17, 2026 |
| Volume | 5,452 |
| Open | 1,498.00 |
| Previous Close | 1,498.00 |
| Day's Range | 1,498.00 - 1,528.00 |
| 52-Week Range | 1,360.00 - 2,090.00 |
| Beta | 0.38 |
| Analysts | Buy |
| Price Target | 1,942.25 (+28.29%) |
| Est. Earnings | Oct 29, 2026 |
About PPHE Hotel Group
PPHE Hotel Group Limited owns, co-owns, develops, leases, operates, and franchises hospitality real estate in the Netherlands, the United Kingdom, Germany, Croatia, Austria, Hungary, Italy, and Serbia. The company focuses on full-service upscale, upper upscale, and lifestyle hotels in cities and regional, as well as resort and campsite properties in select resort destinations. It owns and operates hotels and resorts under the Park Plaza, the art’otel, Holmes, Radisson Collection, and the Arena Campsites brands, as well as the Arena Hotels & Apa... [Read more]
Financial Performance
In 2025, PPHE Hotel Group's revenue was 466.40 million, an increase of 5.33% compared to the previous year's 442.79 million. Earnings were 13.19 million, a decrease of -53.25%.
Financial StatementsAnalyst Summary
According to 3 analysts, the average rating for PPH stock is "Buy." The 12-month stock price target is 1,942p, which is an increase of 28.29% from the latest price.
News
Wednesday's ETF Movers: PPH, SILJ
In trading on Wednesday, the VanEck Pharmaceutical ETF is outperforming other ETFs, up about 2.9% on the day. Components of that ETF showing particular strength include shares of Astrazeneca, up about...
Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
Sector ETF report for PPH
VanEck Pharmaceutical ETF vs VanEck Biotech ETF: Which Fund Is Better for Drug Innovation Profits?
PPH offers higher income and lower volatility, while BBH delivers stronger growth but with deeper drawdowns.
Should You Bet Big on Drugmakers? VanEck Pharmaceutical ETF vs. Invesco Healthcare ETF Compared.
PPH offers concentrated pharma exposure with 1.9% yield and lower volatility, while RSPH provides broader diversification across 60 healthcare holdings.
Tuesday's ETF Movers: COPX, PPH
In trading on Tuesday, the Global X Copper Miners ETF is outperforming other ETFs, up about 5.5% on the day. Components of that ETF showing particular strength include shares of Ivanhoe Electric, up a...
PPHE Hotel Group Earnings Call Transcript: H1 2026
Solid H1 2026 results with 4.7% revenue and 8% EBITDA growth, led by strong U.K. performance. Strategic review ended without a sale, but balance sheet was strengthened through key acquisitions and refinancing. Outlook remains positive despite regional headwinds.
PPHE Hotel Group Quarterly report: H1 2026
PPHE Hotel Group has published its H1 2026 quarterly earnings report on August 27, 2026.
PPHE Hotel Group Slides: H1 2026
PPHE Hotel Group has posted slides in relation to its H1 2026 quarterly earnings report, which was published on August 27, 2026.
Which Healthcare ETF Is the Better Buy: VanEck's Pharma PPH or State Street's Biotech XBI?
PPH offers the income and stability of proven pharmaceutical leaders while XBI swings for the fences across 155 smaller biotech names.
Tuesday's ETF Movers: PPH, PTF
In trading on Tuesday, the VanEck Pharmaceutical ETF is outperforming other ETFs, up about 2% on the day. Components of that ETF showing particular strength include shares of Bausch Health Companies, ...
PPH vs. IYH: Which Healthcare Fund Is the Better Buy?
PPH concentrates on just 26 drugmakers, while IYH diversifies more broadly across 100 healthcare holdings.
Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
Sector ETF report for PPH
Monday's ETF Movers: URA, PPH
In trading on Monday, the Global X Uranium ETF is outperforming other ETFs, up about 4.2% on the day. Components of that ETF showing particular strength include shares of Nano Nuclear Energy, up about...
Is the VanEck Pharmaceutical ETF or State Street Health Care ETF the Better Buy for Your Portfolio?
PPH targets drugmakers exclusively with higher returns but steeper costs, while XLV diversifies across medical equipment and providers at a fraction of the fee.
Concentrated Pharma Exposure or Broader Global Healthcare? PPH vs. IXJ
The VanEck Pharmaceutical ETF (PPH) gives investors a concentrated way to own major drugmakers, while the iShares Global Healthcare ETF (IXJ) spreads exposure across the wider healthcare sector. The c...
For Global Pharma Exposure Is the VanEck Pharmaceutical ETF or iShares Healthcare Fund the Better Buy in 2026?
PPH's concentrated 26-stock portfolio delivered 28% returns over one year, while its 2% dividend yield beats IXJ by 50 basis points.
Vanguard Health Care vs. VanEck Pharmaceutical: How Do These ETFs Stack Up?
VHT offers broad diversification across 429 healthcare holdings, while PPH concentrates on 26 drugmakers for higher growth potential.
PPHE Hotel Group shares tank as Fattal exits takeover talks
PPHE shares fall sharply after Fattal abandons takeover bid as another suitor interest emerges reported. The post PPHE Hotel Group shares tank as Fattal exits takeover talks appeared first on Investom...
Netherland's PPHE says Fattal's $1.22 billion bid not deliverable
PPHE Hotel Group on Friday said a £920.9 million ($1.22 billion) takeover offer from Israel's Fattal Hotel Group was no longer deliverable, after its largest shareholder opposed the bid.
PPHE Hotel Group Jumps 24% on Takeover Approach
Israeli hotel giant Fattal tables £22-per-share cash offer for FTSE 250 hospitality group. The post PPHE Hotel Group Jumps 24% on Takeover Approach appeared first on Investomania .